Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1995-12-07
1998-12-15
Cunningham, Thomas M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
4241851, 4241921, 4242721, 435 693, 435 697, 530350, 530395, A61K 39015, C07K 14445
Patent
active
058493069
ABSTRACT:
The present invention provides isolated polypeptides useful in the treatment and prevention of malaria caused by Plasmodium falciparum or P. vivax. In particular, the polypeptides are derived from the binding domains of the proteins in the EBL family as well as the sialic acid binding protein (SABP) on P. falciparum merozoites. The polypeptides may also be derived from the Duffy antigen binding protein (DABP) on P. vivax merozoites.
REFERENCES:
patent: 5198347 (1993-03-01), Miller et al.
Borst, et al., Antigenic Variation in Malaria, Cell 82:1-4, Jul. 14, 1995.
Chitnis, Chetan E., and Miller, Louis H., Identification of the Erythrocyte Binding Domains . . . , J. Exper. Med. 180:497-506, Aug. 1994.
Sim, et al., Receptor and Ligand Domains for Invasion of Erythrocytes by Plasmodium Falciparum, Science 264:1941-1944, Jun. 24 1994.
Su, et al., The Large Diverse gene Family var Encodes Proteins Involved in Cytoadherence and Antigenic . . . , Cell 82:89-100, Jul. 14, 1995.
Barnwell, J.W., et al., "In vitro Evaluation of the Role of the duffy Blood Group in Erythrocyte Invasion by Plasmodium Vivax, " J. Exp. Med., 169:1795-1802 (May 1989).
Sim, B.K.L., et al., "Primary Structure of the 175K Plasmodium falciparum Erythrocyte Binding Antigen and Identification of a Peptide Which Elicits Antibodies That Inhibit Malaria Merozite Invasion", J. of Cell Biology, 111:1877-1884 (Nov. 1990).
Haynes, J.D., et al., "Receptor-Like Specificity of a Plasmodium Knowlesi Malarial Protein the Binds to Duffy Antigen Ligands on Erythrocytes," J. Exp. Med., 167:1873-1881 (Jun. 1988).
Miller, L.H., et al., "Identification of Plasmodium knowlesi erythrocyte binding proteins," Molecular and Biochemical Parasitology, 31:217-222 (1988).
Wertheimer, S.P., et al., "Plasmodium vivax Interaction with the Human Duffy Blood Group glycoprotein: Identification of a Parasite Receptor-like Protein," Experimental Parasitology, 69:340-350 (1989).
Adams, J.H., et al., "A family of erythrocyte binding proteins of malaria parasites," Proc. Natl. Acad. Sci. USA, 89:7085-7089 (Aug. 1992).
Dalton, J.P., et al., "Blocking the receptor-mediated invasion of erythrocytes by Plasmodium knowlesi malaria with sulfated polysaccharides and glycosaminoglycans," Eur. J. Biochem., 195:789-794 (1991).
Orlandi, P.A., et al., "Characterization of the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum," Molecular and Biochemical Parasitology, 40:285-294 (1990).
Holt, E.H., et al., "Erythrocyte Invasion by two Plasmodium Falciparum Isolates Differing in Sialic Acid Dependency in the Presence of Glycophorin A Antibodies," Am. J. Trop. Med. Hyg., 40(3):245-251 (Mar. 1989).
Perkins, M.E., et al., "Sialic Acid-Dependent Binding of Plasmodium falciparum Merozoite Surface Antigen, Pf200, to Human Erythrocytes," J. of Immunology, 141(9):3190-3196 (Nov. 1, 1988).
Chitnis Chetan
Miller Louis H.
Peterson David S.
Sim Kim Lee
Su Xin-Zhuan
Cunningham Thomas M.
The United States of America as represented by the Department of
LandOfFree
Binding domains from Plasmodium vivax and Plasmodium falciparum does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Binding domains from Plasmodium vivax and Plasmodium falciparum , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Binding domains from Plasmodium vivax and Plasmodium falciparum will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1455250